Quantcast
Last updated on April 18, 2014 at 16:08 EDT

Latest Merial Stories

2014-02-19 16:21:15

DUBLIN, Feb. 19, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/frs7k2/animalveterinary ) has announced the addition of the "Concise Analysis of the International Animal/Veterinary Vaccines Market - Global Forecast to 2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The animal vaccines market studied is segmented by products, animal diseases, and technologies that are involved in developing vaccines for...

2014-01-30 23:27:34

Session to Focus on Merial’s Use of Integrated Loyalty Marketing and Proprietary Customer Segmentation Cincinnati, OH (PRWEB) January 30, 2014 Leading animal pharmaceutical company Merial will discuss how it partnered with rDialogue to re-establish Merial’s loyalty strategy at the highly anticipated 7th Annual Loyalty Expo, presented by Loyalty360 – The Loyalty Marketer’s Association. The event is scheduled for March 17-19, 2014, at the Hyatt Grand Cypress in Orlando, Florida. The...

2013-10-21 20:21:28

DUBLIN, Ireland, October 21, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/gcksr4/animalveterinary) has announced the addition of the "Animal/Veterinary Vaccines Market by Products, Diseases & Technology - Global Forecast to 2018" [http://www.researchandmarkets.com/research/gcksr4/animalveterinary ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The Global Animal Vaccines...

2013-09-25 08:30:37

Merial continues a long history of commitment to eliminating rabies as a global health threat to animals and humans DULUTH, Ga., Sept. 25, 2013 /PRNewswire/ -- As World Rabies Day approaches on September 28, Merial is celebrating by commemorating 30 years of rabies prevention through the use of its IMRAB(®) vaccine, along with numerous other efforts in the fight against rabies worldwide. Rabies is a fatal disease that kills an estimated 70,000 people worldwide annually,[1] with more than 95...

2013-08-06 12:25:20

Americans Cast More than One Million Votes and Pick Country's Eight Most Courageous Canines; Final Voting by Public and Top Celebrities Begins Now to Choose 2013 "American Hero Dog" WASHINGTON, Aug. 6, 2013 /PRNewswire-USNewswire/ -- The country has spoken. After intense balloting and more than one million votes cast, eight courageous canines have been chosen as America's "top dogs" and will be going to Hollywood, where one heroic hound will be named the 2013 American Hero Dog at...

2013-05-02 08:36:08

Growth platforms(2) sales increased 8.6%(3) PARIS, May 2, 2013 /PRNewswire/ -- Sanofi (NYSE: SNY; EURONEXT: SAN) Q1 2013 Change (reported) Change (CER) Net sales EUR8,059m -5.3% -2.8% Business net income(1) EUR1,613m -33.5% -28.8% Business EPS(1) EUR1.22 -33.3% -29.0% In order to facilitate an understanding of our...

2013-04-01 12:26:10

YARDLEY, Pa., April 1, 2013 /PRNewswire/ -- The sale of privately-held Velcera, Inc. ("Velcera") -- a leading pet health company committed to providing consumers with best-in-class pet health products that contain the same active ingredients as branded veterinary products but at a significantly lower cost -- to Allegan-Mich.-based Perrigo Company (Nasdaq: PRGO; TASE) closed today for approximately $160 million in cash. Velcera and its FidoPharm subsidiary is best known for its flea and tick...

2013-03-28 12:30:35

YARDLEY, Pa., March 28, 2013 /PRNewswire/ -- Now that flea and tick season has arrived, pet parents are looking for the best way to protect their dogs and cats. PetArmor(®) is the No. 1 Frontline(®) Top Spot(®) generic containing the No. 1 vet-recommended active ingredient for flea and tick protection, and only PetArmor(®) is backed by 20 clinical trials to prove its effectiveness and safety. Most recently, PetArmor(®) was featured on NBC's "TODAY" as a money-saving tip,...

2013-03-15 08:26:40

GAITHERSBURG, Md., March 15, 2013 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVC) will report financial results for the fourth quarter and year ended December 31, 2012 on Friday, March 22, 2013, before the U.S. financial markets open. The announcement will be followed by a webcast and conference call at 10:00 a.m. EDT to discuss the company's fourth quarter and 2012 financial results and 2013 business outlook. To listen to the live conference call, please dial 877-558-0567 (U.S. or Canada) or...

2013-03-12 08:29:32

GAITHERSBURG, Md., March 12, 2013 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) announced today that Cindy Collins, GenVec's President and CEO, will present a Company overview highlighting recent developments starting at 4:00 p.m. PDT/7:00 p.m. EDT on Tuesday, March 19th at the upcoming 25th Annual ROTH OC Growth Stock Conference in Laguna Niguel, California. A webcast of Ms. Collins' presentation will be available both live and on replay. The presentation will be available via webcast at...